查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2078181

癌症基因組檢測市場：按檢測類型、癌症類型、技術、最終用戶、生物標記類型、服務供應商、應用、檢測環境和地區分類

Genomic Cancer Testing Market, By Test Type, By Cancer Type, By Technology, By End-User, By Biomarker Type, By Service Provider, By Application, By Testing Setting, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年，癌症基因組檢測市場規模將達257.2億美元，2033年將達到767.3億美元。預計從2026年到2033年，該市場將以16.9%的複合年成長率成長。

分析範圍 分析詳情
基準年 2025 市場規模（2026 年） 257.2億美元
效能數據 2020-2024 預測期 2026-2033
預測期（2026-2033 年）複合年成長率 16.90% 預計金額（2033 年） 767.3億美元

癌症基因組檢測正在迅速改變腫瘤學領域。它分析癌細胞的基因組成，從而深入了解驅動患者疾病進展的突變。這種個人化方法使臨床醫生能夠根據個體的基因譜最佳化治療方案，並選擇直接針對現有異常的療法。腫瘤基因組分析有助於預測對特定藥物的反應，識別提示高復發風險的基因標記，並精確定位可阻斷以抑制癌症生長的生物學路徑。隨著基因組技術的不斷進步，癌症檢測正變得更加全面和經濟。預計這將在未來幾年顯著改善許多癌症患者的治療效果。

市場動態：

全球癌症基因組檢測市場的主要驅動力是日益加重的全球癌症負擔以及由此帶來的精準醫療需求成長。次世代定序（NGS）技術在生物標記識別方面的廣泛應用也推動了市場成長。然而，缺乏必要的基因組分析基礎設施和專業技術人員仍然是一項重大挑戰，尤其是在開發中國家。高成本的檢測成本進一步限制了其普及。儘管如此，來自公共和私人機構的資金支持，用於開發新的診斷工具，帶來了可觀的商業機會。診斷公司與癌症中心之間的合作旨在擴大基因組分析的覆蓋範圍。其他旨在檢測可操作基因組突變和檢驗伴隨診斷的策略措施將進一步刺激癌症基因組檢測市場的發展。此外，市場參與者之間合作的加強預計將在預測期內推動市場成長。例如，2023年4月，人工智慧（AI）和精準醫療領域的領導者Tempus宣佈在禮來公司的支持下建立新的合作關係。此次合作旨在擴大合格的進行性或轉移性甲狀腺髓樣癌 (MTC) 或進行性或轉移性非髓樣甲狀腺癌 (非 MTC) 患者獲得基因組檢測的機會。透過此次合作，Tempus 將免費提供分子譜分析服務，並為醫生提供支持，幫助他們利用各種基因組檢測手段，為患者提供數據驅動的治療。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
  • 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本節根據公司概況、產品系列、主要趨勢、財務表現和策略等各種參數，對全球癌症基因組檢測市場的主要公司進行介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
  • 《全球癌症基因組檢測市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球癌症基因組檢測市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 癌症發生率增加
    • 高成本
    • 癌症發生率增加
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 併購情景

第4章：全球癌症基因組檢測市場

  • 供給面和需求面分析
  • 經濟影響

第5章：全球癌症基因組檢測市場：依檢測類型分類（2021-2033 年）

  • 基因組分析測試
  • 液態生物檢體
  • 伴隨診斷檢查
  • 藥理基因體學檢測
  • 遺傳性癌症檢測
  • 其他專門的基因組檢測

第6章：全球癌症基因組檢測市場：依癌症類型分類（2021-2033 年）

  • 乳癌
  • 肺癌
  • 結腸癌
  • 攝護腺癌
  • 卵巢癌
  • 黑色素瘤
  • 白血病
  • 淋巴瘤
  • 其他特定癌症

第7章 全球癌症基因組檢測市場：依技術分類（2021-2033 年）

  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 螢光原位雜合反應（FISH）
  • 微陣列
  • 免疫組織化學（IHC）
  • 其他基因組檢測技術

第8章：全球癌症基因組檢測市場：以最終用戶分類（2021-2033 年）

  • 醫院
  • 診斷檢查室
  • 學術和研究機構
  • 癌症中心
  • 其他醫療保健提供者

第9章 全球癌症基因組檢測市場：依生物標記類型分類（2021-2033 年）

  • 基因生物標記
  • 蛋白質生物標記
  • 分子生物標記
  • 表觀遺傳生物標記

第10章：全球癌症基因組檢測市場：按服務供應商（2021-2033 年）

  • 診斷檢查室
  • 生技公司
  • 製藥公司
  • CRO（委外研發機構）

第11章 全球癌症基因組檢測市場：按地區分類（2021-2033 年）

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第12章 競爭格局

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen NV
  • F.Hoffmann-La Roche Ltd.
  • Foundation Medicine, Inc.（Roche）
  • Invitae Corporation
  • NeoGenomics Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Genomic Health, Inc.（Exact Sciences Corporation）
  • Caris Life Sciences
  • ArcherDX, Inc.（Invitae Corporation）
  • Guardant Health, Inc.
  • Personal Genome Diagnostics Inc.
  • Biocept, Inc.
  • Tempus Labs, Inc.

第13章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5914

Genomic Cancer Testing Market is estimated to be valued at USD 25.72 Bn in 2026 and is expected to reach USD 76.73 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 25.72 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 16.90% 2033 Value Projection: USD 76.73 Bn

Genomic cancer testing is rapidly transforming the field of oncology. It involves analyzing the genetic makeup of cancer cells to gain insights into the mutations driving a patient's disease. This personalized approach enables clinicians to tailor treatment based on an individual's genetic profile and select therapeutics that directly target the abnormalities present. The genomic analysis of a tumor helps predict response to certain drugs, checks for genetic markers that may indicate higher risk of recurrence, and pinpoints biological pathways that can be blocked to stop cancer growth. With continued advances in genomic technologies, cancer testing is becoming more comprehensive and affordable. This is expected to significantly improve outcomes for many cancer patients in the coming years.

Market Dynamics:

The global genomic cancer testing market is primarily driven by rising cancer burden worldwide and subsequent demand for precision medicine approaches. Growing application of next-generation sequencing (NGS) technologies for biomarker identification is also fueling market growth. However, lack of infrastructure and skilled professionals required for genomic analysis poses a major challenge, especially in developing nations. High cost of testing procedures further limits widespread adoption. Yet funding from private and public bodies to develop novel diagnostic tools presents lucrative opportunities. Partnerships between diagnostic companies and cancer centers aim to expand access to genomic profiling. Other strategic initiatives to detect actionable genomic alterations and validate companion diagnostics will further stimulate the genomic cancer testing market. MOrevoer, increasing collaboration between market players is expected to drive the market growth over forecast period. For instance, in April 2023, Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration sponsored by Eli Lilly and Company designed to expand access to genomic testing for eligible patients who have advanced or metastatic medullary thyroid cancer (MTC) OR advanced or metastatic non-medullary thyroid cancer (non-MTC). This collaboration offers Tempus' molecular profiling offerings at no cost while simultaneously working with physicians to support them in providing data-driven treatment to their patients with the use of broad-panel genomic testing.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global genomic cancer testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc. (Roche), Invitae Corporation, NeoGenomics Laboratories, Inc., Myriad Genetics, Inc., Genomic Health, Inc. (Exact Sciences Corporation), Caris Life Sciences, ArcherDX, Inc. (Invitae Corporation), Guardant Health, Inc., Personal Genome Diagnostics Inc., Biocept, Inc., and Tempus Labs, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global genomic cancer testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genomic cancer testing market

Detailed Segmentation:

  • Global Genomic Cancer Testing Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
  • Genomic Profiling Tests
  • Liquid Biopsy Tests
  • Companion Diagnostic Tests
  • Pharmacogenomic Tests
  • Hereditary Cancer Tests
  • Other specialized genomic tests
  • Global Genomic Cancer Testing Market, By Cancer Type (Revenue, USD Bn, 2021 - 2033)
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Melanoma
  • Leukemia
  • Lymphoma
  • Other specific cancer types
  • Global Genomic Cancer Testing Market, By Technology (Revenue, USD Bn, 2021 - 2033)
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In Situ Hybridization (FISH)
  • Microarray
  • Immunohistochemistry (IHC)
  • Other genomic testing technologies
  • Global Genomic Cancer Testing Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutions
  • Cancer Centers
  • Other healthcare providers
  • Global Genomic Cancer Testing Market, By Biomarker Type (Revenue, USD Bn, 2021 - 2033)
  • Genetic Biomarkers
  • Protein Biomarkers
  • Molecular Biomarkers
  • Epigenetic Biomarkers
  • Global Genomic Cancer Testing Market, By Service Provider (Revenue, USD Bn, 2021 - 2033)
  • Diagnostic Laboratories
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Global Genomic Cancer Testing Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Targeted Therapy Selection
  • Disease Monitoring
  • Prognostic Testing
  • Companion Diagnostics
  • Risk Assessment
  • Pharmacogenomic Testing
  • Global Genomic Cancer Testing Market, By Testing Setting (Revenue, USD Bn, 2021 - 2033)
  • In-House Testing
  • Outsourced Testing
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd.
  • Foundation Medicine, Inc. (Roche)
  • Invitae Corporation
  • NeoGenomics Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Genomic Health, Inc. (Exact Sciences Corporation)
  • Caris Life Sciences
  • ArcherDX, Inc. (Invitae Corporation)
  • Guardant Health, Inc.
  • Personal Genome Diagnostics Inc.
  • Biocept, Inc.
  • Tempus Labs, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Genomic Cancer Testing, By Test Type
    • Market Genomic Cancer Testing, By Cancer Type
    • Market Genomic Cancer Testing, By Technology
    • Market Genomic Cancer Testing, By End User
    • Market Genomic Cancer Testing, By Biomarker Type
    • Market Genomic Cancer Testing, By Service Provider
    • Market Genomic Cancer Testing, By Application
    • Market Genomic Cancer Testing, By Testing Setting
    • Market Genomic Cancer Testing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing Cancer Incidence
    • High Costs
    • Increasing Cancer Incidence
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER€(TM)s Analysis
  • Merger and Acquisition Scenario

4. Global Genomic Cancer Testing Market €"

  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Genomic Cancer Testing Market , By Test Type, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Genomic Profiling Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Liquid Biopsy Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Companion Diagnostic Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Pharmacogenomic Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Hereditary Cancer Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other specialized genomic tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Genomic Cancer Testing Market , By Cancer Type, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Colorectal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Ovarian Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Melanoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Leukemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other specific cancer types
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Genomic Cancer Testing Market , By Technology, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Next-Generation Sequencing (NGS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Fluorescence In Situ Hybridization (FISH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Microarray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Immunohistochemistry (IHC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other genomic testing technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Genomic Cancer Testing Market , By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Academic and Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Cancer Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Other healthcare providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Global Genomic Cancer Testing Market , By Biomarker Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Genetic Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Protein Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Molecular Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Epigenetic Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

10. Global Genomic Cancer Testing Market , By Service Provider, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€" 2033
    • Segment Trends
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

11. Global Genomic Cancer Testing Market , By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022€"2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033,(US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region , 2021 - 2033,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

12. Competitive Landscape

  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Qiagen N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • F.Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Foundation Medicine, Inc. (Roche)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Invitae Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NeoGenomics Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Myriad Genetics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Genomic Health, Inc. (Exact Sciences Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Caris Life Sciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ArcherDX, Inc. (Invitae Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Guardant Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Personal Genome Diagnostics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biocept, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Tempus Labs, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views
  • Analyst Views

13. Section

  • Research Methodology
  • About us